nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ESR1—AP-1 transcription factor network—CRTC1—ocular cancer	0.0328	0.0328	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—E2F5—ocular cancer	0.0243	0.0243	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—E2F4—ocular cancer	0.0238	0.0238	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—RBL1—ocular cancer	0.0233	0.0233	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—RBBP4—ocular cancer	0.0233	0.0233	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—GNA11—ocular cancer	0.0225	0.0225	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—GNAQ—ocular cancer	0.0209	0.0209	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—RBBP4—ocular cancer	0.0202	0.0202	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—TFDP1—ocular cancer	0.0188	0.0188	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.0162	0.0162	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.0141	0.0141	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.0135	0.0135	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—HDAC1—ocular cancer	0.0132	0.0132	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—CDK2—ocular cancer	0.0131	0.0131	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—HDAC1—ocular cancer	0.0126	0.0126	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—CDK4—ocular cancer	0.0124	0.0124	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.0122	0.0122	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.012	0.012	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0118	0.0118	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.0117	0.0117	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—HDAC1—ocular cancer	0.0109	0.0109	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—RB1—ocular cancer	0.0108	0.0108	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—E2F1—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.0101	0.0101	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.01	0.01	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.0098	0.0098	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—CDK4—ocular cancer	0.00945	0.00945	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00937	0.00937	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—RB1—ocular cancer	0.00821	0.00821	CbGpPWpGaD
Toremifene—ESR1—FOXA1 transcription factor network—CDKN1B—ocular cancer	0.00809	0.00809	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00808	0.00808	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—CCND1—ocular cancer	0.00801	0.00801	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.0078	0.0078	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.00776	0.00776	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—EP300—ocular cancer	0.00737	0.00737	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.00733	0.00733	CbGpPWpGaD
Toremifene—ESR1—Estrogen signaling pathway—AKT1—ocular cancer	0.00721	0.00721	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0072	0.0072	CbGpPWpGaD
Toremifene—ESR1—FOXA1 transcription factor network—EP300—ocular cancer	0.0071	0.0071	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00685	0.00685	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00664	0.00664	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00664	0.00664	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—MYC—ocular cancer	0.00642	0.00642	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00634	0.00634	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—MYC—ocular cancer	0.0063	0.0063	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00622	0.00622	CbGpPWpGaD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.0061	0.0061	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—CCND1—ocular cancer	0.0061	0.0061	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—E2F5—ocular cancer	0.00608	0.00608	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00597	0.00597	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00597	0.00597	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—E2F4—ocular cancer	0.00595	0.00595	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—RBL1—ocular cancer	0.00584	0.00584	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	0.00572	0.00572	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—CDKN1B—ocular cancer	0.00571	0.00571	CbGpPWpGaD
Toremifene—CYP1A1—Tryptophan metabolism—MDM2—ocular cancer	0.00566	0.00566	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—EP300—ocular cancer	0.00562	0.00562	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CDKN1B—ocular cancer	0.00558	0.00558	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00546	0.00546	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—CCND1—ocular cancer	0.00545	0.00545	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CCND1—ocular cancer	0.00532	0.00532	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	0.00526	0.00526	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—TP53—ocular cancer	0.00518	0.00518	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00517	0.00517	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00517	0.00517	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00515	0.00515	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ocular cancer	0.00514	0.00514	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—CCND1—ocular cancer	0.00504	0.00504	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SF3B1—ocular cancer	0.00499	0.00499	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00493	0.00493	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—EP300—ocular cancer	0.0049	0.0049	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00477	0.00477	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00471	0.00471	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—TFDP1—ocular cancer	0.00471	0.00471	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00469	0.00469	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.00459	0.00459	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00458	0.00458	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ocular cancer	0.00454	0.00454	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00454	0.00454	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00454	0.00454	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00453	0.00453	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00445	0.00445	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—MYC—ocular cancer	0.00437	0.00437	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00436	0.00436	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—TGFB1—ocular cancer	0.00436	0.00436	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MYC—ocular cancer	0.00427	0.00427	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TGFB1—ocular cancer	0.00426	0.00426	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00423	0.00423	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00396	0.00396	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00395	0.00395	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00393	0.00393	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00391	0.00391	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00387	0.00387	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.0038	0.0038	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MAML2—ocular cancer	0.00374	0.00374	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00369	0.00369	CbGpPWpGaD
Toremifene—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.00361	0.00361	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—EIF1AX—ocular cancer	0.00352	0.00352	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TP53—ocular cancer	0.00351	0.00351	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.0033	0.0033	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.0033	0.0033	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.0033	0.0033	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—MDM2—ocular cancer	0.00329	0.00329	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—HRAS—ocular cancer	0.00317	0.00317	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00311	0.00311	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00304	0.00304	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—AKT1—ocular cancer	0.00303	0.00303	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.003	0.003	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CDKN1B—ocular cancer	0.003	0.003	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—E2F5—ocular cancer	0.00293	0.00293	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—E2F4—ocular cancer	0.00287	0.00287	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RBL1—ocular cancer	0.00281	0.00281	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPL39—ocular cancer	0.00281	0.00281	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—AKT1—ocular cancer	0.0028	0.0028	CbGpPWpGaD
Toremifene—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00279	0.00279	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CDKN1A—ocular cancer	0.00277	0.00277	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00274	0.00274	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—HDAC1—ocular cancer	0.00273	0.00273	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00272	0.00272	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00265	0.00265	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00263	0.00263	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00261	0.00261	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PSPH—ocular cancer	0.00257	0.00257	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00252	0.00252	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00252	0.00252	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.0025	0.0025	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RBBP4—ocular cancer	0.00244	0.00244	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.0024	0.0024	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00238	0.00238	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00231	0.00231	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00231	0.00231	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—TFDP1—ocular cancer	0.00227	0.00227	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	0.00226	0.00226	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SAG—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSPH—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—E2F5—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—E2F4—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RBL1—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—HRAS—ocular cancer	0.0018	0.0018	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAML2—ocular cancer	0.0018	0.0018	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSPH—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—AKT1—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—E2F3—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TFDP1—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HDAC1—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSPH—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CDKN2B—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAML2—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GNA11—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—ocular cancer	0.00095	0.00095	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GNAQ—ocular cancer	0.000949	0.000949	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HDAC1—ocular cancer	0.000856	0.000856	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000831	0.000831	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GNA11—ocular cancer	0.000809	0.000809	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN2B—ocular cancer	0.000767	0.000767	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GNAQ—ocular cancer	0.000752	0.000752	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—E2F1—ocular cancer	0.000704	0.000704	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000702	0.000702	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNA11—ocular cancer	0.000646	0.000646	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000607	0.000607	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNAQ—ocular cancer	0.000601	0.000601	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNA11—ocular cancer	0.000516	0.000516	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNAQ—ocular cancer	0.00048	0.00048	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—ocular cancer	0.000457	0.000457	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MDM2—ocular cancer	0.000426	0.000426	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNA11—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1B—ocular cancer	0.000389	0.000389	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000387	0.000387	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—ocular cancer	0.000371	0.000371	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNAQ—ocular cancer	0.00037	0.00037	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1A—ocular cancer	0.000359	0.000359	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EP300—ocular cancer	0.000341	0.000341	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—ocular cancer	0.000297	0.000297	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—ocular cancer	0.000297	0.000297	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—EP300—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—EP300—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—EP300—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—EP300—ocular cancer	0.000133	0.000133	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—ocular cancer	0.000104	0.000104	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—ocular cancer	8.04e-05	8.04e-05	CbGpPWpGaD
